LEAP THERAPEUTICS, INC.

Analyst Reco. Leap Therapeutics, Inc.

Equities

LPTX

US52187K2006

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-08 pm EDT			5-day change	1st Jan Change
1.93 ^USD	-3.50%		+3.21%	-53.44%

Jul. 01	Leap Therapeutics, Inc.(NasdaqCM:LPTX) added to Russell 3000E Index	CI
Jul. 01	Leap Therapeutics, Inc.(NasdaqCM:LPTX) added to Russell Microcap Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Leap Therapeutics to $5.50 From $7, Maintains Buy Rating	May. 14	MT
Baird Adjusts Price Target on Leap Therapeutics to $9 From $11, Maintains Outperform Rating	Mar. 19	MT
Mizuho Securities Adjusts Price Target on Leap Therapeutics to $12 From $20, Maintains Buy Rating	Nov. 20	MT
Baird Lowers Price Target on Leap Therapeutics to $20 From $30, Maintains Outperform Rating	23-08-15	MT
Raymond James Adjusts Price Target on Leap Therapeutics to $18.50 From $17, Maintains Outperform Rating	23-07-13	MT
Raymond James Adjusts Price Target on Leap Therapeutics to $17 From $20, Keeps Outperform Rating	23-06-23	MT
Raymond James Adjusts Price Target on Leap Therapeutics to $2 From $2.50, Maintains Outperform Rating	23-03-27	MT
Mizuho Adjusts Price Target on Leap Therapeutics to $2 From $3, Maintains Buy Rating	23-03-17	MT
Mizuho Securities Adjusts Price Target on Leap Therapeutics to $3 From $6, Maintains Buy Rating	23-01-27	MT
HC Wainwright Lowers Price Target on Leap Therapeutics to $2.50 From $4, Maintains Buy Rating	23-01-18	MT
Raymond James Adjusts Price Target on Leap Therapeutics to $2.50 From $3.50, Maintains Outperform Rating	22-11-11	MT
Raymond James Adjusts Leap Therapeutics' Price Target to $3 from $4, Keeps Outperform Rating	22-07-13	MT
Piper Sandler Adjusts Leap Therapeutics' Price Target to $4 From $6, Reiterates Overweight Rating	22-05-31	MT
Piper Sandler Adjusts Leap Therapeutics' Price Target to $6 From $5, Reiterates Overweight Rating	22-01-24	MT
LEAP THERAPEUTICS : Mizuho Securities Starts Leap Therapeutics at Buy With $6 Price Target	21-10-04	MT
LEAP THERAPEUTICS : Raymond James Lifts Leap Therapeutics' Price Target to $4 from $3, Keeps Outperform Rating	21-09-14	MT
ANALYST RECOMMENDATIONS : American express, CrowdStrike, Five Below, J.M. Smucker, Lululemon...	21-06-07
LEAP THERAPEUTICS : Baird Starts Leap Therapeutics at Outperform with $5 Price Target	21-06-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer